301
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Reduced central corneal thickness in patients with isotretinoin treatment

, , , &
Pages 318-321 | Received 08 Oct 2014, Accepted 05 Nov 2014, Published online: 19 Jan 2015

References

  • Stern RS. Acne therapy. Medication use and sources of care in office-based practice. Arch Dermatol 1996;132:776–780
  • Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358–384
  • Cunliff WJ, van der Kerkhof PCM, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Pharm Treatment 1997;194:351–357
  • Kim RH, Armstrong AW. Current state of acne treatment: highlighting lasers, photodynamic therapy, and chemical peels. Dermatol Online J 2011;17:2
  • DiGiovanna JJ. Systemic retinoid therapy. Dermatol Clin 2001;19:161–167
  • Leyden JJ, James WD. Staphylococcus aureus infection as a complication of isotretinoin therapy. Arch Dermatol 1987;123:606–608
  • Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142:1016–1022
  • Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am J Gastroenterol 2009;104:2774–2778
  • Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45:515–519
  • Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol 2001;132:299–305
  • Neudorfer M, Goldshtein I, Shamai-Lubovitz O, et al. Ocular adverse effects of systemic treatment with isotretinoin. Arch Dermatol 2012;148:803–808
  • Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland morphology and tear osmolarity: changes with accutane therapy. Cornea 1991;10:286–290
  • Lambert RW, Smith RE. Pathogenesis of blepharoconjunctivitis complicating 13-cis-retinoic acid (isotretinoin) therapy in a laboratory model. Invest Ophthalmol Vis Sci 1988;29:1559–1564
  • Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol 2000;44:367–408
  • Solomon OD. Corneal stress test for extended wear. CLAO J 1996;22:75–78
  • Auffarth GU, Wang L, Völcker HE. Keratoconus evaluation using the Orbscan Topography System. J Cataract Refract Surg 2000;26:222–228
  • de Sanctis U, Missolungi A, Mutani B, et al. Reproducibility and repeatability of central corneal thickness measurement in keratoconus using the rotating Scheimpflug camera and ultrasound pachymetry. Am J Ophthalmol 2007;144:712–718
  • Akyol-Salman I, Azisi S, Mumcu U, et al. Central corneal thickness in patients with meibomian gland dysfunction. Clin Exp Optom 2011;94:464–467
  • Cumurcu T, Sener S, Ozsoy E, Doganay S. Changes in anterior chamber parameters with the Pentacam rotating scheimpflug and axial length measurements by ultrasound in patients who use isotretinoin. Curr Eye Res 2012;37:395–398
  • Lin PY, Tsai SY, Cheng CY, et al. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 2003;110:1096–1101
  • Swartz T, Marten L, Wang M. Measuring the cornea: the latest developments in corneal topography. Curr Opin Ophthalmol 2007;18:325–333
  • Harper CL, Boulton ME, Bennett D, et al. Diurnal variations in human corneal thickness. Br J Ophthalmol 1996;80:1068–1072
  • Feng Y, Varikooty J, Simpson TL. Diurnal variation of corneal and corneal epithelial thickness measured using optical coherence tomography. Cornea 2001;20:480–483
  • Stewart ME, Benoit AM, Stranieri AM, et al. Effect of oral 13-cis-retinoic acid at three dose levels on sustainable rates of sebum secretion and on acne. J Am Acad Dermatol 1983;8:532–538
  • King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982;107:583–590
  • Farrell LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial. J Am Acad Dermatol 1980;3:602–611
  • Landthaler M, Kummermehr J, Wagner A, Plewig G. 13-cis-Retinoic acid inhibits sebaceous glands in animals and humans: planimetry and in-vitro autoradiography. J Invest Dermatol 1980;74:453
  • Karalezli A, Borazan M, Altinors DD, et al. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Cornea 2009;28:46–50
  • Knop E, Knop N, Millar T, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 2011;52:1938–1978
  • Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 1995;113:1266–1270
  • Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol 2008;43:170–179
  • Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf 2004;2:149–165
  • Sanchis-Gimeno JA, Lleó-Pérez A, Alonso L, et al. Reduced corneal thickness values in postmenopausal women with dry eye. Cornea 2005;24:39–44
  • Liu Z, Pflugfelder SC. Corneal thickness is reduced in dry eye. Cornea 1999;18:403–407
  • Yeh S, Song XJ, Farley W, et al. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci 2003;44:124–129
  • Rismondo V, Ubels JL. Isotretinoin in lacrimal gland fluid and tears. Arch Ophthalmol 1987;105:416–420
  • White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol 1998;39:34–37
  • Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008;58:56–59

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.